Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference

DSpace/Manakin Repository

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference

Citable link to this page

 

 
Title: Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference
Author: Woodward, Wendy A.; Cristofanilli, Massimo; Merajver, Sofia D.; Van Laere, Steven; Pusztai, Lajos; Bertucci, Francois; Berditchevski, Fedor; Polyak, Kornelia; Overmoyer, Beth; Devi, Gayathri R.; Sterneck, Esta; Schneider, Robert; Debeb, Bisrat G.; Wang, Xiaoping; van Golen, Kenneth L.; El-Zein, Randa; Rahal, Omar M.; Alexander, Angela; Reuben, James M.; Krishnamurthy, Savitri; Lucci, Anthony; Ueno, Naoto T.

Note: Order does not necessarily reflect citation order of authors.

Citation: Woodward, W. A., M. Cristofanilli, S. D. Merajver, S. Van Laere, L. Pusztai, F. Bertucci, F. Berditchevski, et al. 2017. “Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.” Journal of Cancer 8 (17): 3607-3614. doi:10.7150/jca.21200. http://dx.doi.org/10.7150/jca.21200.
Full Text & Related Files:
Abstract: In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians and Texas and New Mexico State legislators led to the formation of a dedicated IBC Research Program and Clinic at MD Anderson. This initiative provided funding and infrastructure to foster coordination of an IBC World Consortium of national and international experts, and launch the first ever IBC international conference in 2008, which brought together experts from around the world to facilitate collaborations and accelerate progress. Indeed great progress has been made since then. National and international experts in IBC convened at the 10th Anniversary Conference of the MD Anderson IBC Clinic and Research Program and presented the most extensive sequencing analysis to date comparing IBC to non-IBC, gene- and protein-based immunoprofiling of IBC versus non-IBC patients, and converging lines of evidence on the specific role of the microenvironment in IBC. Novel models, unique metabolic mechanisms, and prominent survival pathways have been identified and were presented. Multiple clinical trials based on the work of the last decade are in progress or in development. The important challenges ahead were discussed. This progress and a coordinated summary of these works are presented herein.
Published Version: doi:10.7150/jca.21200
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687177/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34493182
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters